Upgrade to SI Premium - Free Trial

Acumen Pharmaceuticals, Inc (ABOS)

2.26 +0.01 (0.44%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/17/26)

Latest Headlines

Form 4 Acumen Pharmaceuticals, For: Jun 15 Filed by: Porter Derrell June 17, 2026 5:10 PM - SEC Filing Form 144 Acumen Pharmaceuticals, Filed by: Porter Derrell June 17, 2026 4:02 PM - SEC Filing JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform June 17, 2026 12:30 PM - BizWire Form 144 Acumen Pharmaceuticals, Filed by: Porter Derrell June 16, 2026 5:04 PM - SEC Filing Form 8-K Acumen Pharmaceuticals, For: Jun 12 June 16, 2026 7:34 AM - SEC Filing ACUMEN Pharmaceuticals nominates two Alzheimer's drug candidates June 16, 2026 7:32 AM - StreetInsider Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease June 16, 2026 7:30 AM - StreetInsider Form 144 Acumen Pharmaceuticals, Filed by: Porter Derrell June 15, 2026 6:32 PM - SEC Filing Form 4 Acumen Pharmaceuticals, For: Jun 09 Filed by: Fountain Nathan B June 10, 2026 4:51 PM - SEC Filing Form 144 Acumen Pharmaceuticals, Filed by: Fountain Nathan B June 9, 2026 4:16 PM - SEC Filing Form 4 Acumen Pharmaceuticals, For: Jun 03 Filed by: Kolchinsky Peter June 5, 2026 5:13 PM - SEC Filing Form 4 Acumen Pharmaceuticals, For: Jun 03 Filed by: Fountain Nathan B June 5, 2026 4:32 PM - SEC Filing Form 4 Acumen Pharmaceuticals, For: Jun 03 Filed by: Drapkin Kimberlee C June 5, 2026 4:32 PM - SEC Filing Form 4 Acumen Pharmaceuticals, For: Jun 03 Filed by: Stalfort John A III June 5, 2026 4:32 PM - SEC Filing Form 4 Acumen Pharmaceuticals, For: Jun 03 Filed by: Porter Derrell June 5, 2026 4:30 PM - SEC Filing Form 4 Acumen Pharmaceuticals, For: Jun 03 Filed by: Ives Jeffrey L. June 5, 2026 4:30 PM - SEC Filing Form 4 Acumen Pharmaceuticals, For: Jun 03 Filed by: Golumbeski George June 5, 2026 4:29 PM - SEC Filing Form 4 Acumen Pharmaceuticals, For: Jun 03 Filed by: Stoppel Laura June 5, 2026 4:28 PM - SEC Filing Form 8-K Acumen Pharmaceuticals, For: Jun 03 June 3, 2026 4:43 PM - SEC Filing Form 10-Q Acumen Pharmaceuticals, For: Mar 31 May 12, 2026 5:16 PM - SEC Filing Form 8-K Acumen Pharmaceuticals, For: May 12 May 12, 2026 7:08 AM - SEC Filing Acumen Pharmaceuticals, Inc. (ABOS) Tops Q1 EPS by 4c May 12, 2026 7:06 AM - StreetInsider Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights May 12, 2026 7:01 AM - Globe NewsWire Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference May 7, 2026 4:00 PM - StreetInsider Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026 May 5, 2026 4:00 PM - Globe NewsWire Form ARS Acumen Pharmaceuticals, For: Dec 31 April 23, 2026 7:19 PM - SEC Filing Form DEF 14A Acumen Pharmaceuticals, For: Dec 31 April 23, 2026 7:19 PM - SEC Filing Form DEFA14A Acumen Pharmaceuticals, April 23, 2026 7:19 PM - SEC Filing Form SCHEDULE 13G Acumen Pharmaceuticals, Filed by: MURRAY JAMES B JR April 7, 2026 4:07 PM - SEC Filing Form EFFECT Acumen Pharmaceuticals, April 2, 2026 6:07 AM - SEC Filing Form 424B3 Acumen Pharmaceuticals, April 1, 2026 5:16 PM - SEC Filing Acumen Pharmaceuticals, Inc (ABOS) files for 10.83M share offering by selling stockholders March 26, 2026 4:32 PM - StreetInsider Form S-3 Acumen Pharmaceuticals, March 26, 2026 4:30 PM - SEC Filing Form S-8 Acumen Pharmaceuticals, March 26, 2026 4:10 PM - SEC Filing Form 10-K Acumen Pharmaceuticals, For: Dec 31 March 26, 2026 4:08 PM - SEC Filing Stifel Reiterates Buy Rating on Acumen Pharmaceuticals, Inc. (ABOS) following in-line Q4 March 26, 2026 12:49 PM - StreetInsider Form 8-K Acumen Pharmaceuticals, For: Mar 26 March 26, 2026 7:05 AM - SEC Filing Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights March 26, 2026 7:00 AM - StreetInsider Acumen Pharmaceuticals (ABOS) Reiterated at Overweight by Cantor Fitzgerald March 26, 2026 6:56 AM - StreetInsider Full Article List